Most importantly, low expression of KIBRA, along with an increased YAP/TAZ target connective tissue growth factor (CTGF) expression, was found to correlate with claudin-low breast cancer cell lines, as well as in claudin-low primary breast tumors, which, generally, are aggressive and have a poor prognosis. The gene discussed is CCN2; the disease is breast carcinoma.